Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06149624 · ClinicalTrials.gov registry record · NA

Supervised Treadmill Intervention to Reduce Inflammation and Depression Through Exercise in HIV: The STRIDE Pilot Study

A NA study of Depression and HIV, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT06149624 is a NA study of Depression and HIV that has completed, run by University of Minnesota. The registered enrollment target is 22 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06149624, a NA study of Depression and HIV, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

Depression in people living with HIV is associated with worse care engagement, drug adherence, and higher rates of pre-mature mortality. The prevalence of depression is three times greater in those with HIV than comparable controls. While antiretroviral therapy (ART) enables immune reconstitution, those with depression do worse clinically than those without depression even when controlling for HIV stage. However, treating depression in HIV-infected persons is challenging. Even among those virologically suppressed on ART, a significant percentage are resistant to standard pharmacotherapy or psychotherapy for depression. The reasons for this are complex and poorly understood. An emerging body of evidence indicates that inflammation may perpetuate depression. Given people with HIV have ongoing increased inflammation, this could help explain part of why depression rates are so high in people with HIV. Treatments for HIV-associated depression would likely be more effective if they were anti- inflammatory in nature. One possible treatment is exercise. Exercise is acutely pro-inflammatory due to catabolism but in the long term is anti-inflammatory. However, few studies have investigated exercise as a treatment for HIV-associated depression. The study objective is to perform a feasibility study to evaluate a larger trial evaluating the efficacy of exercise as an intervention for depression in people with HIV.

Conditions Studied

Interventions

  • BEHAVIORAL upfront advice to walk
  • BEHAVIORAL Supervised exercise

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2024-07-01
Est. Completion 2025-04-15
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT06149624

The ClinicalTrials.gov registry entry for NCT06149624 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which upfront advice to walk is the first listed.

NCT06149624 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06149624 about?

NCT06149624 is a clinical study titled "Supervised Treadmill Intervention to Reduce Inflammation and Depression Through Exercise in HIV: The STRIDE Pilot Study". Depression in people living with HIV is associated with worse care engagement, drug adherence, and higher rates of pre-mature mortality. The prevalence of depression is three times greater in those with HIV than comparable controls. While antiretroviral therapy (ART) enables immune reconstitution, t...

What is the current status of trial NCT06149624?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2024-07-01. Estimated completion is 2025-04-15.

What conditions does trial NCT06149624 study?

This clinical trial studies the following conditions: Depression, HIV.

What interventions are being tested in trial NCT06149624?

The interventions under investigation include: upfront advice to walk (BEHAVIORAL), Supervised exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT06149624?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06149624 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.